Trademark: 87178937
Word
TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG
Status Date
Friday, November 27, 2020
Filing Date
Wednesday, September 21, 2016
Published for Opposition
Tuesday, April 3, 2018
Abandoned Date
Tuesday, November 17, 2020
44 Providing online information services, namely, prescription drug information in relation to the treatment and symptoms of disorders relating to oncology, autoimmune, or inflammatory diseases
Color is not claimed as a feature of the mark.
"ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG"
The mark consists of the wording "TECENTRIQ ATEZOLIZUMAB INJECTION FOR INTRAVENOUS USE 1200 MG" in stylized font, wherein three arrows pointing inwards appears in the upper left of the wording "TECENTRIQ".
Apr 23, 2021
Teas Change Of Correspondence Received
Apr 23, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 23, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 23, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 27, 2020
Abandonment Notice E-Mailed - Failure To Respond
Nov 27, 2020
Abandonment - Failure To Respond Or Late Response
May 15, 2020
Notification Of Final Refusal Emailed
May 15, 2020
Final Refusal E-Mailed
May 15, 2020
Su - Final Refusal - Written
May 14, 2020
Teas/Email Correspondence Entered
May 13, 2020
Correspondence Received In Law Office
May 13, 2020
Teas Response To Office Action Received
Nov 18, 2019
Notification Of Non-Final Action E-Mailed
Nov 18, 2019
Non-Final Action E-Mailed
Nov 18, 2019
Su - Non-Final Action - Written
Nov 16, 2019
Statement Of Use Processing Complete
Nov 6, 2019
Use Amendment Filed
Nov 16, 2019
Case Assigned To Intent To Use Paralegal
Nov 6, 2019
Teas Statement Of Use Received
May 8, 2019
Notice Of Approval Of Extension Request E-Mailed
May 6, 2019
Extension 2 Granted
May 6, 2019
Extension 2 Filed
May 6, 2019
Teas Extension Received
Nov 7, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2018
Extension 1 Granted
Nov 5, 2018
Extension 1 Filed
Nov 5, 2018
Teas Extension Received
May 29, 2018
Noa E-Mailed - Sou Required From Applicant
Apr 3, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2018
Published For Opposition
Mar 14, 2018
Notification Of Notice Of Publication E-Mailed
Feb 28, 2018
Approved For Pub - Principal Register
Feb 13, 2018
Teas/Email Correspondence Entered
Feb 13, 2018
Correspondence Received In Law Office
Feb 12, 2018
Assigned To Lie
Feb 5, 2018
Teas Response To Office Action Received
Aug 3, 2017
Notification Of Non-Final Action E-Mailed
Aug 3, 2017
Non-Final Action E-Mailed
Aug 3, 2017
Non-Final Action Written
Aug 2, 2017
Previous Allowance Count Withdrawn
Jul 25, 2017
Withdrawn From Pub - Og Review Query
Jul 3, 2017
Approved For Pub - Principal Register
Jun 23, 2017
Examiner's Amendment Entered
Jun 23, 2017
Notification Of Examiners Amendment E-Mailed
Jun 23, 2017
Examiners Amendment E-Mailed
Jun 23, 2017
Examiners Amendment -Written
Jan 4, 2017
Notification Of Non-Final Action E-Mailed
Jan 4, 2017
Non-Final Action E-Mailed
Jan 4, 2017
Non-Final Action Written
Dec 28, 2016
Assigned To Examiner
Sep 28, 2016
Notice Of Design Search Code E-Mailed
Sep 27, 2016
New Application Office Supplied Data Entered In Tram
Sep 24, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
